Concepts of fever

Archives of Internal Medicine

Volumn 158, Issue 17, 1998, Pages 1870-1881

  Mackowiak, Philip A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; PYROGEN;

ACUTE PHASE RESPONSE; BODY TEMPERATURE; EVOLUTION; FEVER; HUMAN; OSCILLATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; THERMOMETER; THERMOMETRY; THERMOREGULATION;

CYTOKINES; FEVER; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; PYROGENS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032575904     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.17.1870     Document Type: Review

References (171)

1. Mackowiak PA, Wasserman SS. Physicians' perceptions regarding body temperature in health and disease. South Med J. 1995;88:934-938.
2. Majno G. The Healing Hand: Man and Wound in the Ancient World. Cambridge, Mass: Harvard University Press; 1975:57.
3. Galen. Opera omnia. In: Siegel RE, ed. Galen's System of Physiology and Medicine. Vol 11. New York, NY: Karger; 1968.
4. Atkins E. Fever: its history, cause and function. Yale J Biol Med. 1982;55:283-287.
5. Berger RL, Clem TR, Harden VA, Mangum BW. Historical development and newer means of temperature measurements in biochemistry. Methods Biochem Anal. 1984;269-331.
6. Bolton HC. Evolution of the Thermometer 1592-1743. Easton, Pa: Chemical Publishing Co; 1900: 18, 98.
7. Wunderlich CRA. Das Verhalten der Eigenwärme in Krankenheiten. Leipzig, Germany: Otto Wigard; 1868.
8. Mackowiak PA, Worden G. Carl Reinhold August Wunderlich and the evolution of clinical thermometry. Clin Infect Dis. 1994;18:458-467.
9. Mackowiak PA, Wasserman SS, Levine MM. A critical appraisal of 98.6°F: the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA. 1992; 268:1578-1580.
10. IUPS Thermal Commission. Glossary of terms for thermal physiology: second edition. Pflugers Arch. 1987;410:567-587.
11. Boulant JA. Thermoregulation. In Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1997:35-58.
12. Bruck K. Heat balance and the regulation of body temperature. In: Schmidt RF, Thews G, eds. Human Physiology. Berlin, Germany: Springer-Verlag; 1983:531-547.
13. Stanier MW, Mount LE, Bligh J. Energy Balance and Temperature Regulation. Cambridge, England: Cambridge University Press; 1984.
14. Boulant JA. Hypothalamic control of thermoregulation: neurophysiological basis. In: Morgane PJ, Pankepp J, eds. Handbook of the Hypothalamus. Vol 3, part A. New York, NY: Marcel Dekker Inc; 1980:1-82.
15. Schonung W, Wagner H, Jessen C, Simon E. Differentiation of cutaneous and intestinal blood flow during hypothalamic heating and cooling in anesthetized dogs. Pflugers Arch. 1971;328:145-154.
16. Mackowiak PA, Boulant JA. Fever's glass ceiling. Clin Infect Dis. 1996;22:525-536.
17. Boulant JA. Hypothalamic neurons regulating body temperature. In: Fregly MJ, Blatteis CM, eds. APS Handbook of Physiology. New York, NY: Oxford University Press; 1996:105-126.
18. Hammel HT, Jackson DC, Stolwijk JAJ, Hardy JD, Stromme SB. Temperature regulation by hypothalamic proportional control with an adjustable set point. J Appl Physiol. 1963;18:1146-1154.
19. Hammel HT. Neurons and temperature regulation. In: Yamamoto WS, Brobeck JR, eds. Physiological Controls and Regulations. Philadelphia, Pa: WB Saunders Co; 1965:71-97.
20. Sawka MN, Wenger CB. Physiological responses to acute exercise-heat stress. In: Pandolf KB, Sawka MN, Gonzalez RR, eds. Human Performance Physiology and Environmental Medicine at Terrestrial Extremes. Indianapolis, Ind: Benchmark Press; 1988:97-151.
21. Bligh J. Temperature Regulation in Mammals and Other Vertebrates. Amsterdam, the Netherlands: North Holland; 1973.
22. Stitt JT. Prostaglandin E as the mediator of the febrile response. Yale J Biol Med. 1986;59:137-149.
23. Mitchell D, Laburn HP, Cooper KE, Hellon RF, Cranstoon WI, Townsend Y. Is prostaglandin E the neural mediator of the febrile response? the case against a proven obligatory role. Yale J Biol Med 1986;59:159-168.
24. Dinarello CA. Cytokines as endogenous pyrogens. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:87-116.
25. Mickenberg ID, Snyderman R, Root RK, Mergenhagen SE, Worlff SM. The relationship of complement consumption to immune fever. J Immunol. 1971;107:1466-1476.
26. Arend WP, Joslin FG, Massoni RJ. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol. 1985;134:3868-3875.
27. Dillard GM, Bodel P. Studies on steroid fever, II: pyrogenic and anti-pyrogenic activity in vitro of some endogenous steroids of man. J Clin Invest. 1970;49:2418-2426.
28. Kappas A, Hellman L, Fukushima DK, Gallagher TF. The pyrogenic effect of etiocholanolone [letter]. J Clin Endocrinol Metab. 1957;17:451-453.
29. Wolff SM, Kimball HR, Perry S, Root RK, Kappas A. The biological properties of etiocholanolone. Ann Intern Med. 1967;67:1268-1295.
30. Bondy PK, Bodel P. Mechanism of action of pyrogenic and antipyretic steroids in vitro. In: Wolstenholme GEW, Birch J, eds. Pyrogens and Fever. Edinburgh, Scotland: Churchill Livingstone Inc; 1971;101-113.
31. Goodman MG, Chenoweth DE, Weigle WO. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J Exp Med. 1982;156:912-917.
32. Atkins E, Feldman JD, Francis L, Hursh E. Studies on the mechanism of fever accompanying delayed hypersensitivity: the role of the sensitized lymphocyte. J Exp Med. 1972;135:1113-1132.
33. Bernheim HA, Block LH, Francis L, Atkins E. Release of endogenous pyrogen-activating factor from concanavalin A - stimulated human lymphocytes. J Exp Med. 1980;152:1811-1816.
34. Dinarello CA. Demonstration of a human pyrogen-inducing factor during mixed leukocyte reactions. J Exp Med. 1981;153:1215-1224.
35. Mackowiak PA, Barlett JG, Borden EC, et al. Fever: recent advances and lingering dogma. Clin Infect Dis. 1997;25:119-138.
36. Kushner I, Rzewnicki DL. The acute phase response. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997: 165-176.
37. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106-113.
38. Dinarello C. The interleukin-1 family: 10 years of discovery. FASEB J. 1994;8:1314-1325.
39. Dinarello C. Interleukin-1. Adv Pharmacol. 1994; 25:21-51.
40. Fiers W. Tumor necrosis factor: characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991;285:199-212.
41. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10: 411-452.
42. Tracey K, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491-503.
43. Brach M, Herrman F. Interleukin 6: presence and future. Int J Clin Lab Res. 1992;22:143-151.
44. Lotz M. Interleukin-6. Cancer Invest. 1993;11: 731-742.
45. Jones T. Interteukin-6 an endocrine cytokine. Clin Endocrinol. 1994;40:703-713.
46. 2: a putative fever mediator. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:117-145.
47. Kluger M. Fever: role of pyrogens and cryogens. Physiol Rev. 1991;71:93-127.
48. Michie HR, Managua KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 1988; 318:1481-1486.
49. Klostergaard J, Barta M, Tomasovic SP. Hyperthermic modulation of tumor necrosis factor-dependent monocyte/macrophage tumor cytotoxicity in vitro. J Biol Res Mod. 1989;8:262-277.
50. Tomasovic SP, Klostergaard J. Hyperthermic modulation of macrophage-tumor cell interactions. Cancer Metastasis Rev. 1989;8:215-229.
51. Fouqueray B, Philippe C, Amrani A, Perez J, Baud L. Heat shock prevents lipopolysaccharide-induced tumor necrosis factor-α synthesis by rat mononuclear phagocytes. Eur J Immunol. 1992; 22:2983-2987.
52. Snyder Y, Guthrie ML, Evans GF, Zuckerman SH. Transcriptional inhibition of endotoxin-induced monokine synthesis following heat shock in murine peritoneal macrophages. J Leukoc Biol. 1992; 51:181-187.
53. Valasco S, Tarlow M, Olsen K, et al. Temperature-dependent modulation of lipopolysaccharide-induced interleukin-1β and tumor necrosis factor-α expression in cultured human astroglia by dexamethasone and indomethacin. J Clin Invest. 1991;87:1674-1680.
54. Kappel, M, Diamant M, Hansen MB, Klokker M, Pedersen PK. Effects of in vitro hyperthermia on the proliferative response of blood mononuclear cell subsets, and detection of interleukins 1 and 6, tumor necrosis factor-alpha and interferon-gamma. Immunology. 1991;73:304-308.
55. Ensor JE, Wiener SM, McCrea KA, Viscardi RM, Crawford EK, Hasday JD. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-α expression. Am J Physiol Cell Physiol. 1994;266:C967-C974.
56. Ensor JE, Crawford EK, Hasday JD. Warming macrophages to febrile range destabilizes tumor necrosis factor-α mRNA without inducing heat shock. Am J Physiol Cell Physiol. 1995; 269:C1140-C1146.
57. Weiner S, Hasday JD. Temperature dependence of monocyte cytokine release. FASEB J. 1991;5:A626.
58. Costa J, DeTolla L, Piper J, Ensor J, Hasday JD. Effects of febrile range temperature on cytokine expression in lipopolysaccharide-challenged mice. FASEB J. 1995;9:A960.
59. Aderka D, Le J, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol. 1989;143:3517-3523.
60. Cross AS, Sadoff JC, Kelly N, Bernton E, Gemski P. Pretreatment with recombinant murine tumor necrosis factor α/cachectin and murine interleukin 1α protects mice from lethal bacterial infection. J Exp Med. 1989;169:2021-2027.
61. Trey J, Kushner I. The acute phase response and the hematopoietic system: the role of cytokines. Crit Rev Oncol Hematol. 1995;21:1-18.
62. Schilling RF. Anemia of chronic disease: a misnomer. Ann Intern Med. 1991;115:572-573.
63. Ernst E, Saradeth T, Achhammer G. ω3 fatty acids and acute-phase proteins. Eur J Clin Invest. 1991;21:77-82.
64. Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA, Boswell DR. Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry. 1992;32:1035-1041.
65. Ganguli R, Yang Z, Shurin G, et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res. 1994;51:1-10.
66. LeMay LG, Vander AJ, Kluger MJ. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav. 1990;47:957-961.
67. Volanakis JE. Acute phase proteins. McCarty DJ, Koopman WJ, eds. Arthritis and Allied Conditions: A Textbook of Rheumatology. Malvern, Pa: Lea & Febiger; 1993:469-477.
68. Ballou SP, Lozanski G. Induction of inflammatory cytokines release from cultured human monocytes by C-reactive protein. Cytokine. 1992; 4:361-368.
69. Cermak J, Key NS, Bach RR, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-520
70. Tilg H, Vannier E, Vachine G, Dinarello CA, Mier JW. Anti-inflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J Exp Med. 1993;178:1629-1636.
71. Dobrinich R, Spagnuolo PJ. Binding of C-reactive protein to human neutrophils: inhibition of respiratory burst activity. Arthritis Rheum. 1991;34:1031-1038.
72. Ahmed N, Thorley R, Xia D, Samols D, Webster RO. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am J Respir Crit Care Med. In press.
73. Xu L, Badolato R, Murphy WJ, et al. A novel biologic function of serum amyloid A-induction of T lymphocyte migration and adhesion. J Immunol. 1995;155:1184-1190.
74. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high-density lipoprotein's cellular affinity. Lab Invest. 1992;66:778.
75. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91: 2488-2496.
76. May MT. Galen on the Usefulness of the Parts of the Body. Ithaca, NY: Cornell University Press: 1968:50-53.
77. DuBois EF. Why are fever temperatures over 106°F rare? Am J Med Sci. 1949;217:361-368.
78. Pittman QJ, Wilkinson MF. Central arginine vasopressin and endogenous antipyresis. Can J Physiol Pharmacol. 1992;70:786-790.
79. Pittman QJ, Poulin P, Wilkinson MF. Role of neurohypophysial hormones in temperature regulation. Ann N Y Acad Sci. 1993;689:375-381.
80. Kasting N. Criteria for establishing a physiological role for brain peptides: a case in point: the role of vasopressin in thermoregulation during fever and antipyresis. Brain Res Rev. 1989;14:143-153.
81. Lipton JM. Disorders of temperature control. In: Rieder P, Kopp N, Pearson J, eds. An Introduction to Neurotransmission in Health and Disease. Oxford, England: Oxford University Press; 1990:119-123.
82. Zeisberger E. The role of septal peptides in thermoregulation and fever. In: Bligh J, Voigt K, eds. Thermoreception and Temperature Regulation. Berlin, Germany: Springer-Verlag; 1990:273-283.
83. Glyn JR, Lipton JM. Hypothermic and antipyretic effects of centrally administered ACTH (-24) and α-melanotropin. Peptides. 1981;2:177-187.
84. Glyn-Ballinger JR, Bernardini GL, Lipton JM. α-MSH injected into the septal region reduces fever in rabbits. Peptides. 1983;4:199-203.
85. Lipton JM, Whisenant JD, Gean JT. Hypothermia produced by peripheral and central injections ot chlopromazine in aged rabbits. Brain Res Bull. 1979;4:297-300.
86. Murphy MT, Lipton JM. Peripheral administration of α-MSH reduces fever in older and younger rabbits. Peptides. 1982;13:775-779.
87. Murphy MT, Richard DB, Lipton JM. Antipyretic potency of centrally administered α-melanocyte-stimulating hormone. Science. 1983; 221:192-193.
88. Deeter LB, Martin LW, Lipton JM. Antipyretic effect of central alpha-MSH summates with that of acetaminophen or ibuprofen. Brain Res Bull. 1989;23:573-575.
89. Shih ST, Lipton JM, McCann SM. Central administration of α-MSH antiserum augments fever in the rabbit. Am J Physiol. 1986;250:R803-R806.
90. Feldberg W, Meyers RD. A new concept of temperature regulation by amines in the hypothalamus. Nature. 1963;200:1325.
91. Bligh J. Cells, cell-talk and mammalian homeothermy. In: Bligh J, Voigt K, eds. Thermoreception and Temperature Regulation. Berlin, Germany: Springer-Verlag; 1990:163-173.
92. Morrow LE, McClellan JL, Conn CA, Kluger MJ. Glucocorticoids alter fever and IL-6 responses to psychological stress and to lipopolysaccharide. Am J Physiol. 1993;225:R151-R156.
93. Luedke CE, Cerami A. Interferon-gamma overcomes glucocorticoid suppression of cachectin/ tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest. 1990;86:1234-1240.
94. 2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem. 1990;265:12745-12748.
95. Alexander DP, Bashore RA, Britton HG, Forsling MA. Maternal and fetal arginine vasopressin in the chronically catheterized sheep. Biol Neonate. 1974;25:242-248.
96. Carey F, Forder M, Edge D, et al. Lipocortin 1 fragment modifies pyrogenic actions of cytokines in rats. Am J Physiol. 1990;259:R266-R269.
97. Bernadini GL, Lipton JM, Clark WG. Intracerebroventricular and septal injections of arginine vasopressin are not antipyretic in the rabbit. Peptides. 1983;4:195-198.
98. Riedel W. Role of thyroid-stimulating hormone (TSH) in endogenous antipyresis and evidence of extrahypothalamic thyroid-stimulating neurons (TSN) in rabbits. Pflugers Arch. 1987;408 (suppl):R49.
99. Bahendeka SK, Moor RE, Tomkin GH, Buchanan KD. Gastric inhibitory polypeptide, dietary-induced thermogenesis and obesity. Can J Physiol Pharmacol. 1987;65:1242-1247.
100. Stanley BG, Leibowitz SF, Neuropeptide Y. Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 1984;35: 2635-2642.
101. Jansky L, Vybiral S, Moravec J, et al. Neuropeptides and temperature regulation. J Therm Biol. 1986;11:79-83.
102. Schmid H, Pierau Fr-K. Long-term modulation of hypothalamic neurons by neuropeptides. In: Bligh J, Voigt K, eds. Thermoregulation and Temperature Regulation. Berlin, Germany: Springer-Verlag; 1990:53-63.
103. Gale CC, McCreery BR. Mechanism of bombesin hypothermia. Fed Proc. 1979;38:997.
104. Holt SJ, Grimble RF, York DA. Tumor necrosis factor-α and lymphotoxin have opposite effects on sympathetic efferent nerves to brown adipose tissue by direct action in the central nervous system. Brain Res. 1989;497:183-186.
105. Shih ST, Khorram O, Lipton JM, McCann SM. Central administration of α-MSH antiserum augments fever in the rabbit. Am J Physiol. 1986; 250:R803-R806.
106. Sivo J, Salkowski CA, Politis AD, Vogel SN. Differential regulation of LPS-induced IL-1β and IL-1 receptor antagonist mRNA by IFNα and IFNγ in murine peritoneal macrophages. J Endotoxin Res. 1994;1:30-36.
107. Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HR. A urine inhibitor of interleukin-1 activity that blocks ligand binding. J Immunol. 1987;139:1546-1549.
108. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Thompson RC. Interleukin-1 receptor antagonist is a member of the interleukin-1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci U S A. 1991;88:5232-5236.
109. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-receptor but does not initiate IL-1 signal transduction. J Biol Chem. 1991;266:10331-10336.
110. Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP. Interleukin-1 receptorantagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem. 1991;266:20311-20315.
111. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem. 1989;264:11974-11980.
112. Olsson I, Lantx M, Nilsson E, et al. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol. 1989; 42:270-275.
113. Engleman H, Novick D, Wallach D. Two tumor necrosis factor-binding proteins from human wine. J Biol Chem. 1990;265:1531-1536.
114. Brockhuas M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher M. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA. 1990;87: 3127-3131.
115. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med. 1990;172:599-607.
116. Mackowiak PA. Fever: blessing or curse? a unifying hypothesis. Ann Intern Med. 1994;120: 1037-1040.
117. Kluger MJ, Kozat W, Conn CA, Leon LR, Soszynski D. The adaptive value of fever. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:255-266.
118. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science. 1975;188:166-168.
119. Bernheim HA, Kluger MJ. Fever: Effect of drug-induced antipyresis on survival. Science. 1976; 193:237-239.
120. Covert JR, Reynolds WW. Survival value of fever in fish. Nature. 1977;267:43-45.
121. Schmidt JR, Rasmussen AF Jr. The influence of environmental temperature on the course of experimental herpes simplex infection. J Infect Dis. 1960;107:356-360.
122. Lwoff A. Factors influencing the evolution of viral diseases at the cellular level and in the organism. Bacterial Rev. 1959;23:109-124.
123. Walker DL, Boring WD. Factors influencing host-virus interactions, III: further studies on the alteration of coxsackie virus infection in adult mice by environ mental temperature. J Immunol. 1958; 80:39-44.
124. Bell JF, Moore GJ. Effects of high ambient temperature on various stages of rabies virus infection in mice. Infect Immun. 1974;10:510-515.
125. Kuhn LR. Effect of elevated body temperature on cryptococcus in mice. Proc Soc Exp Biol Med. 1949;71:341-343.
126. Eiseman B, Mallette WG, Wotkyns RS, Summers WB, Tong JL. Prolonged hypothermia in experimental pneumococcal peritonitis. J Clin Invest. 1956;35:940-946.
127. Rich AR, McKee CM. The mechanism of a hitherto unexplained form of native immunity to the type III pneumococcus. Bull Johns Hopkins Hosp. 1936;59:171-207.
128. Kuhn LR. Growth and viability of Cryptococcus hominis at mouse and rabbit body temperatures. Proc Soc Exp Biol Med. 1939;41:573-574.
129. Carmichael LE, Barnes FD. Effect of temperature on growth of canine herpes virus in canine kidney cell and macrophage cultures. J Infect Dis. 1969;120:664-668.
130. Furuchi S, Shimizu Y. Effect of ambient temperatures on multiplication of attenuated transmissible gastroenteritis virus in the bodies of newborn piglets. Infect Immun. 1976;13:990-992.
131. Toms GL, Davies JA, Woodward CG, Sweet C, Smith H. The relation of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence. Br J Exp Pathol. 1977; 588:444-458.
132. Greisman SE. Cardiovascular alterations during fever. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. New York, NY: Raven Press; 1991:143-165.
133. Bryant RE, Hood AF, Hood CE, Koenig MG. Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med. 1971;127:120-128.
134. Mackowiak PA, Browne RH, Southern PM Jr, Smith JW. Polymicrobial sepsis: analysis of 184 cases using log linear models. Am J Med Sci. 1980;280:73-80.
135. Weinstein MR, Iannini PB, Staton CW, Eichoff TC. Spontaneous bacterial peritonitis: a review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med. 1978;64:592-598.
136. Dorn TF, DeAngelis C, Baumgardner RA, et al. Acetaminophen: more harm than good for chicken pox? J Pediatr. 1989;114:1045-1048.
137. Stanley ED, Jackson GG, Panusarn C, et al. Increased viral shedding with aspirin treatment of rhinovirus infection. JAMA. 1975;231:1248-1251.
138. Graham MH, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. 1990;162:1277-1282.
139. Dinarello CA. Endogenous pyrogens: the role of cytokines in the pathogenesis of fever. In: Mackowiak PA, ed. Fever: Basic Mechanisms and Management. New York, NY: Raven Press; 1991:23-47.
140. Mellouk S, Green SJ, Nacy CA, Hoffman SL. IFN-γ inhibits development of Plasmodium bergheiexoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J Immunol. 1991;146:3971-3976.
141. Naotunne TDS, Karunaweera ND, Del Giudice G, et al. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J Exp Med. 1991;173:523-529.
142. Curfs JHAJ, Van Der Meer JWM, Sauerwein RW, Eling WMC. Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med. 1990;172:1287-1291.
143. Woodman JP, Dimier IH, Bout DT. Human endothelial cells are activated by IFN-γ to inhibit Toxoplasmosis gondii replication: inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J Immunol. 1991;147:2019-2023.
144. Liew FY, Li Y, Millott S. Tumor necrosis factor a synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol. 1990;145:4306-4310.
145. Torrico F, Heremans H, Rivera MT, Van Marck E, Billiau A, Carlier Y. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol. 1991;146:3626-3632.
146. + T lymphocytes in protective immunity. J Immunol. 1991;147:1014-1022.
147. Sambhi SK, Kohonen-Corish MRJ, Ramshaw IA. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci U S A. 1991;88:4025-4029.
148. Feduchi E, Carrasco L. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon. Virology. 1991;180:822-825.
149. Strijp HAG, Van Der Tol ME, Miltenburgh LAM, Van Kessel KPM, Verhoff J. Tumor necrosis factor triggers granulocytes to internalize complement-coated virus particles. Immunology. 1991;73:77-82.
150. Hedges S, Anderson P, Lidin-Janson G, Deman P, Svanborg C. Interleukin-6 response to deliberate colonization of the human urinary tract with gramnegative bacteria. Infect Immun. 1991;59:421-427.
151. Vogels MTE, Vander Meer JWM. Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob Agents Chemother. 1992;36:1-5.
152. Bernheim HA, Bodel T, Askenase PW, Atkins E. Effects of fever on host defense mechanisms after injection of the lizard Dipsosaurus dorsalis. Br J Exp Pathol. 1978;59:76-84.
153. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis. 1991;163:1177-1184.
154. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993;119:771-778.
155. Johnson J, Brigham KL, Jesmok G, Meyrick B. Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor α. Am Rev Respir Dis. 1991;144:179-186.
156. Heinzel FP. The role of IFN-γ in the pathology of experimental endotoxemia. J Immunol. 1990; 145:2920-2924.
157. Henricson BE, Neta R, Vogel SN. An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun. 1991;59:1188-1191.
158. Ohlsson K, Björk P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990;348:550-552.
159. Opal SM, Cross AS, Sadoff JC, et al. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis. J Clin Invest. 1991;88:885-890.
160. Overbeek BP, Veringa EM. Role of antibodies and antibiotics in aerobic gram-negative septicemia: possible synergism between antimicrobial treatment and immunotherapy. Rev Infect Dis. 1991;13:751-760.
161. Alexander HR, Sheppard BC, Jensen JC, et al. Treatment with recombinant tumor necrosis fac-tor-alpha protects rats against lethality, hypotension, and hypothermia of gram-negative sepsis. J Clin Invest 1991;88:34-39.
162. Fisher CJ Jr, Agosti JM, Opal SM, et al. Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein. N Engl J Med. 1996;334:1697-1702.
163. Freudenberg MA, Galanos C. Tumor necrosis factor alpha mediates lethal activity of killed gramnegative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun. 1991; 59:2110-2115.
164. Gibson RL, Redding GJ, Henderson WR, Truog WE. Group B streptococcus induces tumor necrosis factor in neonatal piglets: effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. Am Rev Respir Dis. 1991;143:598-604.
165. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood. 1990;76:2303-2310.
166. Radolf JD, Norgard MV, Brandt ME, Isaacs RD, Thompson PA, Beutler B. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. J Immunol. 1991;147:1968-1974.
167. Habicht GS, Katona LI, Benach JL. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J Infect Dis. 1991;164:568-574.
168. Jacobs RF, Jabor DR. The immunology of sepsis and meningitis-cytokine biology. Scand J Infect Dis Suppl. 1990;73:7-15.
169. Jenkins JK, Carey PD, Byrne K, Sugerman, HJ, Fowler AA III. Sepsis-induced lung injury and the effects of ibuprofen pretreatment: analysis of early alveolar events via repetitive bronchoalveolar lavage. Am Rev Respir Dis. 1991;143:155-161.
170. Saez-Llorens X, Jafara HS, Olsen KD, Nariuchi H, Hansen EJ, McCracken, GH. Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-α, and interteukin-1β. J Infect Dis. 1991;163:1267-1272.
171. Rook GAW, Al Attiyah R. Cytokines and the Koch phenomenon. Tubercle. 1991;72:13-20.